Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Infant Bacterial Therapeutics AB (DE:9IB)

FRANKFURT:9IB

9IB

Infant Bacterial Therapeutics AB

RESEARCH TOOLSreports

Infant Bacterial Therapeutics AB (9IB) Ratios

Compare

4 Followers

Infant Bacterial Therapeutics AB Ratios

DE:9IB's free cash flow for Q2 2025 was kr0.00. For the 2025 fiscal year, DE:9IB's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	2.72	3.33	7.40	18.93	30.03
Quick Ratio	2.72	3.33	7.40	18.93	30.03
Cash Ratio	2.55	3.22	7.13	18.75	29.25
Solvency Ratio	-1.14	0.12	0.25	-3.61	-3.34
Operating Cash Flow Ratio	-1.82	-1.63	-2.19	-4.79	-4.21
Short-Term Operating Cash Flow Coverage	0.00	0.00	0.00	0.00	0.00
Net Current Asset Value	kr 97.19M	kr 161.31M	kr 295.38M	kr 321.12M	kr 383.87M
Leverage Ratios
Debt-to-Assets Ratio	0.00	0.00	0.00	0.00	0.00
Debt-to-Equity Ratio	0.00	0.00	0.00	0.00	0.00
Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.54	1.41	1.15	1.05	1.03
Debt Service Coverage Ratio	0.00	0.00	0.00	-219.60	-105.96
Interest Coverage Ratio	0.00	0.00	0.00	-224.60	-107.94
Debt to Market Cap	0.00	0.00	0.00	0.00	0.00
Interest Debt Per Share	0.00	0.00	0.00	0.03	0.04
Net Debt to EBITDA	2.23	1.63	-28.49	5.22	8.84
Profitability Margins
Gross Profit Margin	0.00%	100.00%	100.00%	100.00%	0.00%
EBIT Margin	0.00%	-3422625.00%	-159828.57%	-545425.00%	0.00%
EBITDA Margin	0.00%	-3422625.00%	14998.70%	-536183.33%	0.00%
Operating Profit Margin	0.00%	-3497550.00%	-174827.27%	-548400.00%	0.00%
Pretax Profit Margin	0.00%	-3422625.00%	-159828.57%	-545425.00%	0.00%
Net Profit Margin	0.00%	-3422625.00%	-159828.57%	-545425.00%	0.00%
Continuous Operations Profit Margin	0.00%	-3422625.00%	-159828.57%	-545425.00%	0.00%
Net Income Per EBT	100.00%	100.00%	100.00%	100.00%	100.00%
EBT Per EBIT	94.45%	97.86%	91.42%	99.46%	100.93%
Return on Assets (ROA)	-40.29%	-57.15%	-35.03%	-18.72%	-11.01%
Return on Equity (ROE)	-50.36%	-80.41%	-40.33%	-19.73%	-11.38%
Return on Capital Employed (ROCE)	-65.50%	-82.17%	-44.11%	-19.84%	-11.28%
Return on Invested Capital (ROIC)	-65.50%	-82.17%	-44.11%	-19.84%	-11.28%
Return on Tangible Assets	-42.40%	-59.35%	-36.02%	-19.30%	-11.33%
Earnings Yield	-10.03%	-18.96%	-11.06%	-11.66%	-6.00%
Efficiency Ratios
Receivables Turnover	0.00	<0.01	0.01	<0.01	0.00
Payables Turnover	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00
Asset Turnover	0.00	<0.01	<0.01	<0.01	0.00
Working Capital Turnover Ratio	0.00	<0.01	<0.01	<0.01	0.00
Cash Conversion Cycle	0.00	434.90K	31.93K	54.08K	0.00
Days of Sales Outstanding	0.00	434.90K	31.93K	54.08K	0.00
Days of Inventory Outstanding	0.00	0.00	0.00	0.00	0.00
Days of Payables Outstanding	0.00	0.00	0.00	0.00	0.00
Operating Cycle	0.00	434.90K	31.93K	54.08K	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	-7.63	-8.40	-8.19	-7.64	-4.95
Free Cash Flow Per Share	-7.63	-8.40	-8.19	-7.64	-4.95
CapEx Per Share	0.00	0.00	0.00	0.00	0.00
Free Cash Flow to Operating Cash Flow	1.00	1.00	1.00	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Capital Expenditure Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	0.00	-28.28K	-1.31K	-7.15K	0.00
Free Cash Flow Yield	-16.37%	-15.67%	-9.10%	-15.28%	-7.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-9.97	-5.27	-9.04	-8.58	-16.67
Price-to-Sales (P/S) Ratio	0.00	180.52K	14.45K	46.78K	0.00
Price-to-Book (P/B) Ratio	6.17	4.24	3.65	1.69	1.90
Price-to-Free Cash Flow (P/FCF) Ratio	-6.11	-6.38	-10.99	-6.54	-13.48
Price-to-Operating Cash Flow Ratio	-6.32	-6.38	-10.99	-6.54	-13.48
Price-to-Earnings Growth (PEG) Ratio	-0.55	-2.50	-0.13	-0.19	0.44
Price-to-Fair Value	6.17	4.24	3.65	1.69	1.90
Enterprise Value Multiple	-7.50	-3.64	67.86	-3.50	-8.30
Enterprise Value	484.12M	498.68M	783.75M	225.47M	363.16M
EV to EBITDA	-7.50	-3.64	67.86	-3.50	-8.30
EV to Sales	0.00	124.67K	10.18K	18.79K	0.00
EV to Free Cash Flow	-4.71	-4.41	-7.74	-2.63	-6.53
EV to Operating Cash Flow	-4.71	-4.41	-7.74	-2.63	-6.53
Tangible Book Value Per Share	7.22	11.98	23.89	28.61	34.20
Shareholders’ Equity Per Share	7.82	12.64	24.68	29.55	35.21
Tax and Other Ratios
Effective Tax Rate	0.00	0.00	0.00	0.00	0.00
Revenue Per Share	0.00	<0.01	<0.01	<0.01	0.00
Net Income Per Share	-4.84	-10.16	-9.95	-5.83	-4.01
Tax Burden	1.00	1.00	1.00	1.00	1.00
Interest Burden	1.00	1.00	1.00	1.00	1.01
Research & Development to Revenue	0.00	30.15K	1.57K	5.49K	0.00
SG&A to Revenue	0.00	4.82K	175.47	0.00	0.00
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	0.95	0.78	0.82	1.30	1.25

Currency in SEK